Krilogy Financial LLC Biocryst Pharmaceuticals Inc Transaction History

Krilogy Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$6.51 - $9.6 $1,302 - $1,920	-200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.52 - $7.99 $1,104 - $1,598	200 New	200 $2,000
Q2 2018 Aug 15, 2018	SELL	$4.6 - $6.52 $919 - $1,304	-200 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	200	200 $1,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.